Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-251
Closed -$46K – 123
2026
Q1
$46K Sell
251
-2
-0.8% -$369 0.04% 187
2025
Q4
$44.5K Hold
253
– – 0.03% 203
2025
Q3
$35.4K Hold
253
– – 0.02% 233
2025
Q2
$31.8K Buy
+253
New +$31.5K 0.02% 243
2024
Q3
$64.2K Sell
331
-2
-0.6% -$418 0.05% 165
2024
Q2
$77.2K Buy
+333
New +$72.4K 0.07% 143
2023
Q3
$111K Hold
433
– – 0.12% 106
2023
Q2
$123K Buy
+433
New +$129K 0.12% 100
2023
Q1
– Sell
-442
Closed -$122K – 100
2022
Q4
$122K Buy
+442
New +$125K 0.09% 121
2022
Q3
– Sell
-442
Closed -$90K – 114
2022
Q2
$90K Buy
+442
New +$90.4K 0.08% 123
2022
Q1
– Sell
-442
Closed -$106K – 95
2021
Q4
$106K Hold
442
– – 0.06% 162
2021
Q3
$125K Buy
+442
New +$145K 0.09% 126
2021
Q1
– Sell
-567
Closed -$244K – 96
2020
Q4
$244K Buy
+567
New +$146K 0.06% 36

Other funds holding BIIB

WFA of San Diego's BIIB Position: Q2 2026 in Review

WFA of San Diego sold out of Biogen (BIIB) in Q2 2026, closing a stake of 251 shares — an estimated $46K sold.

WFA of San Diego first reported a position in BIIB in Q4 2020 and held it in 13 quarters. The position peaked at $244K in Q4 2020. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • WFA of San Diego reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
  • WFA of San Diego sold 251 Biogen shares in Q2 2026, an estimated $46K.
  • WFA of San Diego first reported a position in Biogen in Q4 2020 and held it in 13 quarters.
  • WFA of San Diego's Biogen position peaked at $244K in Q4 2020.
  • 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on WFA of San Diego's 13F filing for Q2 2026, filed 14 Aug 2026.